Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

p38γ is essential for cell cycle progression and liver tumorigenesis.

Tomás-Loba A, Manieri E, González-Terán B, Mora A, Leiva-Vega L, Santamans AM, Romero-Becerra R, Rodríguez E, Pintor-Chocano A, Feixas F, López JA, Caballero B, Trakala M, Blanco Ó, Torres JL, Hernández-Cosido L, Montalvo-Romeral V, Matesanz N, Roche-Molina M, Bernal JA, Mischo H, León M, Caballero A, Miranda-Saavedra D, Ruiz-Cabello J, Nevzorova YA, Cubero FJ, Bravo J, Vázquez J, Malumbres M, Marcos M, Osuna S, Sabio G.

Nature. 2019 Apr;568(7753):557-560. doi: 10.1038/s41586-019-1112-8. Epub 2019 Apr 10.

PMID:
30971822
2.

Adiponectin accounts for gender differences in hepatocellular carcinoma incidence.

Manieri E, Herrera-Melle L, Mora A, Tomás-Loba A, Leiva-Vega L, Fernández DI, Rodríguez E, Morán L, Hernández-Cosido L, Torres JL, Seoane LM, Cubero FJ, Marcos M, Sabio G.

J Exp Med. 2019 May 6;216(5):1108-1119. doi: 10.1084/jem.20181288. Epub 2019 Apr 3.

PMID:
30944152
3.

Plasticity of adult hepatocytes and readjustment of cell fate: a novel dogma in liver disease.

Cubero FJ, Martinez-Chantar ML.

Gut. 2019 Jun;68(6):954-956. doi: 10.1136/gutjnl-2019-318218. Epub 2019 Mar 18. No abstract available.

PMID:
30885923
4.

Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.

Cubero FJ, Woitok MM, Zoubek ME, de Bruin A, Hatting M, Trautwein C.

Cell Death Dis. 2019 Feb 8;10(2):115. doi: 10.1038/s41419-019-1391-x.

5.

Unfolded protein response is an early, non-critical event during hepatic stellate cell activation.

Mannaerts I, Thoen LFR, Eysackers N, Cubero FJ, Batista Leite S, Coldham I, Colle I, Trautwein C, van Grunsven LA.

Cell Death Dis. 2019 Feb 4;10(2):98. doi: 10.1038/s41419-019-1327-5.

6.

Alcoholic liver disease: Utility of animal models.

Lamas-Paz A, Hao F, Nelson LJ, Vázquez MT, Canals S, Gómez Del Moral M, Martínez-Naves E, Nevzorova YA, Cubero FJ.

World J Gastroenterol. 2018 Dec 7;24(45):5063-5075. doi: 10.3748/wjg.v24.i45.5063. Review.

7.

Extracellular vesicles in liver disease and beyond.

Morán L, Cubero FJ.

World J Gastroenterol. 2018 Oct 28;24(40):4519-4526. doi: 10.3748/wjg.v24.i40.4519.

8.

Changes in Cerebral Hemodynamics in Patients With Cirrhosis After Liver Transplantation.

Macías-Rodríguez RU, Ruiz-Margáin A, Cantú-Brito C, Flores-Silva DF, García-Flores OR, Cubero FJ, Larrieta-Carrasco E, Torre A.

Liver Transpl. 2018 Dec;24(12):1673-1679. doi: 10.1002/lt.25335.

PMID:
30207422
9.

Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.

Sonntag R, Giebeler N, Nevzorova YA, Bangen JM, Fahrenkamp D, Lambertz D, Haas U, Hu W, Gassler N, Cubero FJ, Müller-Newen G, Abdallah AT, Weiskirchen R, Ticconi F, Costa IG, Barbacid M, Trautwein C, Liedtke C.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9282-9287. doi: 10.1073/pnas.1807155115. Epub 2018 Aug 27.

10.

Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis.

Cubero FJ, Peng J, Liao L, Su H, Zhao G, Zoubek ME, Macías-Rodríguez R, Ruiz-Margain A, Reißing J, Zimmermann HW, Gassler N, Luedde T, Liedtke C, Hatting M, Trautwein C.

J Hepatol. 2018 Dec;69(6):1326-1334. doi: 10.1016/j.jhep.2018.08.015. Epub 2018 Aug 23.

PMID:
30144553
11.

The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease.

Guo F, Zheng K, Benedé-Ubieto R, Cubero FJ, Nevzorova YA.

Alcohol Clin Exp Res. 2018 Oct;42(10):1828-1840. doi: 10.1111/acer.13840. Epub 2018 Aug 9. Review.

PMID:
30025151
12.

Dissecting the molecular pathophysiology of drug-induced liver injury.

Ye H, Nelson LJ, Gómez Del Moral M, Martínez-Naves E, Cubero FJ.

World J Gastroenterol. 2018 Apr 7;24(13):1373-1385. doi: 10.3748/wjg.v24.i13.1373. Review.

13.

Expression of microRNA-155 in inflammatory cells modulates liver injury.

Blaya D, Aguilar-Bravo B, Hao F, Casacuberta-Serra S, Coll M, Perea L, Vallverdú J, Graupera I, Pose E, Llovet L, Barquinero J, Cubero FJ, Caballería J, Ginès P, Sancho-Bru P.

Hepatology. 2018 Aug;68(2):691-706. doi: 10.1002/hep.29833. Epub 2018 May 2.

PMID:
29420849
14.

Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice.

Hao F, Cubero FJ, Ramadori P, Liao L, Haas U, Lambertz D, Sonntag R, Bangen JM, Gassler N, Hoss M, Streetz KL, Reissing J, Zimmermann HW, Trautwein C, Liedtke C, Nevzorova YA.

Cell Death Dis. 2017 Oct 26;8(10):e3152. doi: 10.1038/cddis.2017.532.

15.

Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame.

Ramadori P, Cubero FJ, Liedtke C, Trautwein C, Nevzorova YA.

Cancers (Basel). 2017 Sep 25;9(10). pii: E130. doi: 10.3390/cancers9100130. Review.

16.

Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury.

Sydor S, Manka P, Best J, Jafoui S, Sowa JP, Zoubek ME, Hernandez-Gea V, Cubero FJ, Kälsch J, Vetter D, Fiel MI, Hoshida Y, Bian CB, Nelson LJ, Moshage H, Faber KN, Paul A, Baba HA, Gerken G, Friedman SL, Canbay A, Bechmann LP.

Sci Rep. 2017 Aug 14;7(1):8119. doi: 10.1038/s41598-017-08680-w.

17.

Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.

Ramadori P, Drescher H, Erschfeld S, Fragoulis A, Kensler TW, Wruck CJ, Cubero FJ, Trautwein C, Streetz KL, Kroy DC.

Oxid Med Cell Longev. 2017;2017:3420286. doi: 10.1155/2017/3420286. Epub 2017 Jun 6.

18.

c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.

Zheng K, Cubero FJ, Nevzorova YA.

Genes (Basel). 2017 Apr 19;8(4). pii: E123. doi: 10.3390/genes8040123. Review.

19.

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis.

Ruiz-Margáin A, Macías-Rodríguez RU, Ampuero J, Cubero FJ, Chi-Cervera L, Ríos-Torres SL, Duarte-Rojo A, Espinosa-Cuevas Á, Romero-Gómez M, Torre A.

World J Gastroenterol. 2016 Dec 7;22(45):10064-10070. doi: 10.3748/wjg.v22.i45.10064.

20.

Functional role of CCL5/RANTES for HCC progression during chronic liver disease.

Mohs A, Kuttkat N, Reißing J, Zimmermann HW, Sonntag R, Proudfoot A, Youssef SA, de Bruin A, Cubero FJ, Trautwein C.

J Hepatol. 2017 Apr;66(4):743-753. doi: 10.1016/j.jhep.2016.12.011. Epub 2016 Dec 21.

PMID:
28011329

Supplemental Content

Loading ...
Support Center